Mental Illnesses Market Report: 2017 Global Analysis by Key Players Johnson & Johnson Services Inc., AstraZeneca, Bristol-Myers Squibb Company
The Global Mental Illnesses Market is projected to reach USD 12,542 million during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
View full press release